Luo R - Search Results

1

Idecabtagene vicleucel for relapsed/refractory multiple myeloma: a review of recent advances.

Tu W, Xiao Y, Wang Y, Luo R, Chen ZS. Tu W, et al. Among authors: luo r. Drugs Today (Barc). 2022 Mar;58(3):117-132. doi: 10.1358/dot.2022.58.3.3381592. Drugs Today (Barc). 2022. PMID: 35274631 Review.

2

Increased PA2G4 Expression Is an Unfavorable Factor in Nasopharyngeal Carcinoma.

Xu Y, Cai H, Tu W, Ding L, Luo R. Xu Y, et al. Among authors: luo r. Appl Immunohistochem Mol Morphol. 2021 Aug 1;29(7):513-518. doi: 10.1097/PAI.0000000000000918. Appl Immunohistochem Mol Morphol. 2021. PMID: 33605574 Free PMC article. Clinical Trial.

3

Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.

Xiao Y, Li Y, Tao H, Humphries B, Li A, Jiang Y, Yang C, Luo R, Wang Z. Xiao Y, et al. Among authors: luo r. Cancer Lett. 2018 Oct 1;433:199-209. doi: 10.1016/j.canlet.2018.06.037. Epub 2018 Jun 30. Cancer Lett. 2018. PMID: 29964204

4

[Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer].

Hu X, Jiao S, Zhang S, Wang Z, Wang M, Huang C, Zheng R, Li K, Wang J, Wang Y, Ouyang X, Lv W, Cheng G, Hu C, Luo R, Sun Y. Hu X, et al. Among authors: luo r. Zhongguo Fei Ai Za Zhi. 2012 Oct;15(10):569-75. doi: 10.3779/j.issn.1009-3419.2012.10.02. Zhongguo Fei Ai Za Zhi. 2012. PMID: 23075680 Free PMC article. Clinical Trial. Chinese.

5

[Diagnosis and treatment of multiple endocrine neoplasia type 2A: a case report and literature review].

Yu R, Wu Z, Li A, Jin G, Luo R. Yu R, et al. Among authors: luo r. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jun;34(6):909-12. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24968855 Review. Chinese.

6

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin's Lymphoma.

Xue Y, Lai X, Li R, Ge C, Zeng B, Li Z, Fu Q, Zhao L, Dong S, Yang J, Guo J, Meng Q, Tan Q, Li Z, Ding H, Zhang Y, Liu S, Chang AH, Yao H, Luo R. Xue Y, et al. Among authors: luo r. Front Oncol. 2021 Feb 2;10:607362. doi: 10.3389/fonc.2020.607362. eCollection 2020. Front Oncol. 2021. PMID: 33604290 Free PMC article.

7

Small interfering RNA (siRNA)-mediated knockdown of Notch1 suppresses tumor growth and enhances the effect of IL-2 immunotherapy in malignant melanoma.

Yang Z, Qi Y, Lu C, Zhang J, Luo R, Kang S. Yang Z, et al. Among authors: luo r. J BUON. 2015 Nov-Dec;20(6):1553-64. J BUON. 2015. PMID: 26854453 Free article.

8

Predictive value of microtubule-associated protein Tau in patients with recurrent and metastatic breast cancer treated with taxane-containing palliative chemotherapy.

Zhou J, Qian S, Li H, He W, Tan X, Zhang Q, Han G, Chen G, Luo R. Zhou J, et al. Among authors: luo r. Tumour Biol. 2015 May;36(5):3941-7. doi: 10.1007/s13277-015-3037-7. Epub 2015 Mar 14. Tumour Biol. 2015. PMID: 25773385

9

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.

Liu M, Hu Q, Tu M, Wang X, Yang Z, Yang G, Luo R. Liu M, et al. Among authors: luo r. J Exp Clin Cancer Res. 2018 Jan 22;37(1):10. doi: 10.1186/s13046-017-0669-z. J Exp Clin Cancer Res. 2018. PMID: 29357919 Free PMC article.

10

miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.

Zhao M, Luo R, Liu Y, Gao L, Fu Z, Fu Q, Luo X, Chen Y, Deng X, Liang Z, Li X, Cheng C, Liu Z, Fang W. Zhao M, et al. Among authors: luo r, luo x. Nat Commun. 2016 Apr 20;7:11309. doi: 10.1038/ncomms11309. Nat Commun. 2016. PMID: 27095304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,611 results

Search Page